Kardiellt troponin – en biomarkör för hjärt–kärlsjukdom vid KOL

Mikael Michelini Truedsson, Eeva Piitulainen, Ingrid Alm Hirsch, Johan Malm, György Marko-Varga, Martin Stagmo

Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskriftPeer review

Sammanfattning

Chronic obstructive pulmonary disease (COPD) and cardiovascular disease (CVD) are frequently associated and share common risk factors, pathophysiological processes, symptoms and clinical signs. Ischemic heart disease, heart failure, pulmonary hypertension and atrial fibrillation are common comorbidities of COPD. COPD has been described as an independent risk factor for CVD. Cardiac troponin elevation, indicating myocardial injury, is associated with both the stable state of COPD and acute exacerbation of COPD. The mechanisms of elevated troponin levels in these conditions are multiple and not fully understood. The aim of this article is to discuss the association between COPD, CVD and cardiac troponins.

Bidragets översatta titel Cardiac troponins - biomarkers for cardiovascular disease in chronic obstructive pulmonary disease
Originalspråksvenska
Sidor (från-till)1-5
TidskriftLakartidningen
Volym117
StatusPublished - 2020

Ämnesklassifikation (UKÄ)

  • Kardiologi

Fingeravtryck

Utforska forskningsämnen för ”Kardiellt troponin – en biomarkör för hjärt–kärlsjukdom vid KOL”. Tillsammans bildar de ett unikt fingeravtryck.

Citera det här